Adenovirus VAI RNA antagonizes the RNA-editing activity of the ADAR adenosine deaminase.

The virus-associated VAI RNA of adenovirus is a small highly structured RNA that is required for the efficient translation of cellular and viral mRNAs at late times after infection. VAI RNA antagonizes the activation of the interferon-inducible RNA-dependent protein kinase, PKR, an important regulator of translation. The RNA-specific adenosine deaminase, ADAR, is an interferon-inducible RNA-editing enzyme that catalyzes the site-selective C-6 deamination of adenosine to inosine. ADAR possesses three copies of the highly conserved RNA-binding motif (dsRBM) that are similar to the two copies found in PKR, the enzyme in which the prototype dsRBM motif was discovered. We have examined the effect of VAI RNA on ADAR function. VAI RNA impairs the activity of ADAR deaminase. This inhibition can be observed in extracts prepared from interferon-treated human cells and from monkey COS cells in which wild-type recombinant ADAR was expressed. Analysis of wild-type and mutant forms of VA RNA suggests that the central domain is important in the antagonism of ADAR activity. These results suggest that VAI RNA may modulate viral and cellular gene expression by modulating RNA editing as well as mRNA translation.

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  T. Cech,et al.  Binding of the protein kinase PKR to RNAs with secondary structure defects: role of the tandem A-G mismatch and noncontiguous helixes. , 1998, Biochemistry.

[3]  R. Emeson,et al.  Regulation of serotonin-2C receptor G-protein coupling by RNA editing , 1997, Nature.

[4]  B. Bass,et al.  RNA editing and hypermutation by adenosine deamination. , 1997, Trends in biochemical sciences.

[5]  C. Smith,et al.  A ribonuclease specific for inosine‐containing RNA: a potential role in antiviral defence? , 1997, The EMBO journal.

[6]  Madhur Kumar,et al.  Nuclear antisense RNA induces extensive adenosine modifications and nuclear retention of target transcripts. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Yong Liu,et al.  Functionally Distinct Double-stranded RNA-binding Domains Associated with Alternative Splice Site Variants of the Interferon-inducible Double-stranded RNA-specific Adenosine Deaminase* , 1997, The Journal of Biological Chemistry.

[8]  M. Mathews,et al.  Secondary and tertiary structure in the central domain of adenovirus type 2 VA RNA I. , 1996, RNA.

[9]  K. Kuhen,et al.  Structural organization of the human gene (PKR) encoding an interferon-inducible RNA-dependent protein kinase (PKR) and differences from its mouse homolog. , 1996, Genomics.

[10]  M. Mathews,et al.  Structure, function, and evolution of adenovirus-associated RNA: a phylogenetic approach , 1996, Journal of virology.

[11]  Brenda L. Bass,et al.  RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase , 1996, Nature.

[12]  C. Samuel,et al.  Mechanism of interferon action: functionally distinct RNA-binding and catalytic domains in the interferon-inducible, double-stranded RNA-specific adenosine deaminase , 1996, Journal of virology.

[13]  C. Samuel,et al.  The interferon-inducible, double-stranded RNA-specific adenosine deaminase gene (DSRAD) maps to human chromosome 1q21.1-21.2. , 1995, Genomics.

[14]  C. Samuel,et al.  Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase , 1995, Molecular and cellular biology.

[15]  K. Nishikura,et al.  Mutagenic Analysis of Double-stranded RNA Adenosine Deaminase, a Candidate Enzyme for RNA Editing of Glutamate-gated Ion Channel Transcripts (*) , 1995, The Journal of Biological Chemistry.

[16]  C. Samuel,et al.  Mechanism of interferon action: double-stranded RNA-specific adenosine deaminase from human cells is inducible by alpha and gamma interferons. , 1995, Virology.

[17]  B. Thimmapaya,et al.  Effect of single-base substitutions in the central domain of virus-associated RNA I on its function , 1995, Journal of virology.

[18]  M. Mathews,et al.  Interactions between the double-stranded RNA binding motif and RNA: definition of the binding site for the interferon-induced protein kinase DAI (PKR) on adenovirus VA RNA. , 1995, RNA.

[19]  M. Higuchi,et al.  Cloning of cDNAs encoding mammalian double-stranded RNA-specific adenosine deaminase , 1995, Molecular and cellular biology.

[20]  C. Samuel,et al.  Mechanism of interferon action: RNA-binding activity of full-length and R-domain forms of the RNA-dependent protein kinase PKR--determination of KD values for VAI and TAR RNAs. , 1995, Virology.

[21]  M. Mathews,et al.  Two functionally distinct RNA-binding motifs in the regulatory domain of the protein kinase DAI , 1995, Molecular and cellular biology.

[22]  T Kuner,et al.  Control of kinetic properties of AMPA receptor channels by nuclear RNA editing. , 1994, Science.

[23]  R. Cattaneo,et al.  Biased (A-->I) hypermutation of animal RNA virus genomes. , 1994, Current opinion in genetics & development.

[24]  B. Bass,et al.  Preferential selection of adenosines for modification by double‐stranded RNA adenosine deaminase. , 1994, The EMBO journal.

[25]  K. Nishikura,et al.  Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[26]  W. Keller,et al.  Purification and properties of double-stranded RNA-specific adenosine deaminase from calf thymus. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[27]  C. Samuel,et al.  Mechanism of interferon action: structure of the mouse PKR gene encoding the interferon-inducible RNA-dependent protein kinase. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[28]  D. Speicher,et al.  Purification and characterization of double-stranded RNA adenosine deaminase from bovine nuclear extracts. , 1994, The Journal of biological chemistry.

[29]  B. Bass,et al.  Purification of the Xenopus laevis double-stranded RNA adenosine deaminase. , 1994, The Journal of biological chemistry.

[30]  P. Lengyel.  Tumor-suppressor genes: news about the interferon connection. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[31]  C. Samuel,et al.  The eIF-2 alpha protein kinases, regulators of translation in eukaryotes from yeasts to humans. , 1993, The Journal of biological chemistry.

[32]  Robert H. Silverman,et al.  Expression cloning of 2-5A-dependent RNAase: A uniquely regulated mediator of interferon action , 1993, Cell.

[33]  M. Mathews,et al.  Two RNA-binding motifs in the double-stranded RNA-activated protein kinase, DAI. , 1992, Genes & development.

[34]  D. St Johnston,et al.  A conserved double-stranded RNA-binding domain. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[35]  C. Samuel,et al.  Mechanism of interferon action: cDNA structure, expression, and regulation of the interferon-induced, RNA-dependent P1/eIF-2 alpha protein kinase from human cells. , 1992, Virology.

[36]  C. Samuel,et al.  Mechanism of interferon action: identification of a RNA binding domain within the N-terminal region of the human RNA-dependent P1/eIF-2 alpha protein kinase. , 1992, Virology.

[37]  M. Mathews,et al.  Adenovirus virus-associated RNA and translation control , 1991, Journal of virology.

[38]  K. Nishikura,et al.  Substrate specificity of the dsRNA unwinding/modifying activity. , 1991, The EMBO journal.

[39]  P. Seeburg,et al.  RNA editing in brain controls a determinant of ion flow in glutamate-gated channels , 1991, Cell.

[40]  M. Groudine,et al.  Tat-dependent adenosine-to-inosine modification of wild-type transactivation response RNA. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[41]  C. Samuel,et al.  Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. , 1991, Virology.

[42]  I. Kerr,et al.  Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon , 1990, Cell.

[43]  M. Mathews,et al.  Interaction of adenovirus VA RNAI with the protein kinase DAI: Nonequivalence of binding and function , 1990, Cell.

[44]  G. Akusjärvi,et al.  A novel effect of adenovirus VA RNA1 on cytoplasmic mRNA abundance. , 1990, Virology.

[45]  Y. Yoshikawa,et al.  Generalized and localized biased hypermutation affecting the matrix gene of a measles virus strain that causes subacute sclerosing panencephalitis , 1989, Journal of virology.

[46]  A. Levinson,et al.  Adenovirus VAI‐RNA regulates gene expression by controlling stability of ribosome‐bound RNAs. , 1989, The EMBO journal.

[47]  R. Bhat,et al.  Functional dissection of adenovirus VAI RNA , 1989, Journal of virology.

[48]  Roberto Cattaneo,et al.  Biased hypermutation and other genetic changes in defective measles viruses in human brain infections , 1988, Cell.

[49]  M. Mathews,et al.  Characterization of the double-stranded RNA implicated in the inhibition of protein synthesis in cells infected with a mutant adenovirus defective for VA RNA. , 1988, Virology.

[50]  V. Pathak,et al.  Generation of a mutant form of protein synthesis initiation factor eIF-2 lacking the site of phosphorylation by eIF-2 kinases , 1988, Molecular and cellular biology.

[51]  C. Samuel,et al.  Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2α kinase , 1986, Cell.

[52]  Michael B. Mathews,et al.  A mechanism for the control of protein synthesis by adenovirus VA RNAI , 1986, Cell.

[53]  T. Shenk,et al.  Adenovirus VAI RNA facilitates the initiation of translation in virus-infected cells , 1984, Cell.

[54]  H. Luthman,et al.  High efficiency polyoma DNA transfection of chloroquine treated cells. , 1983, Nucleic acids research.

[55]  William E. Stewart,et al.  The Interferon System , 1979, Springer Vienna.

[56]  C. E. Samuel.  Mechanism of interferon action: phosphorylation of protein synthesis initiation factor eIF-2 in interferon-treated human cells by a ribosome-associated kinase processing site specificity similar to hemin-regulated rabbit reticulocyte kinase. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[57]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[58]  M. Mathews,et al.  A new species of virus-coded low molecular weight RNA from cells infected with adenovirus type 2 , 1976, Cell.

[59]  M. Berry,et al.  Purification of double-stranded RNA-dependent protein kinase from mouse fibroblasts. , 1986, Methods in enzymology.